CX33 - Satellite Symposia Programme
GORE SATELLITE
11.05-11.35
Innovative approaches for complex lower extremity lesions and aneurysms
Innovative approaches for complex lower extremity lesions and aneurysms
Chairman: Richard Saxon, Oceanside, CA, United States
Lower extremity revascularisation
Walter Dorigo, Florence, Italy
Walter Dorigo, Florence, Italy
GORE® VIABAHN® Endoprosthesis in-stent restenosis trial update
Marc Bosiers, Dendermonde, Belgium
Marc Bosiers, Dendermonde, Belgium
Endoluminal popliteal bypass evidence today and tomorrow
Eric Verhoeven, Nürnberg, Germany
Eric Verhoeven, Nürnberg, Germany
MAQUET SATELLITE
Vascular grafts patency: What the future holds
Chairman: A. Assadian, Austria
Lower limb patency challenges and limitations
Inge Fourneau, Leuven, Belgium
Inge Fourneau, Leuven, Belgium
Peripheral bypass: New directions for improving patency results
Afshin Assadian, Vienna, Austria
Afshin Assadian, Vienna, Austria
Future developments in peripheral vascular surgery
Sriram Iyer, New York, NY, United States
Sriram Iyer, New York, NY, United States
CORDIS SATELLITE
Current treatment modalities, strategies and trends in complex lower extremity lesions
Chairman: Roger Greenhalgh, Imperial College, London, United Kingdom
Endovascular techniques and developments for below the knee revascularisation
Eric Ducasse, Bordeaux, France
Eric Ducasse, Bordeaux, France
Advanced below the knee interventions in diabetic patients
Lanfori Graziani, Brescia, Italy
Lanfori Graziani, Brescia, Italy
The angiosome model of reperfusion and its clinical implementation
Vlad Alexandrescu, Marche-en-Famenne, Belgium
Vlad Alexandrescu, Marche-en-Famenne, Belgium
GORE SATELLITE
09.25-09.55
Challenging necks with GORE® EXCLUDER® AAA Endoprosthesis: From advanced techniques to proven clinical results
Challenging necks with GORE® EXCLUDER® AAA Endoprosthesis: From advanced techniques to proven clinical results
Moderator: Eric Verhoeven, Nürnberg, Germany
No migration after ten years of EVAR with the GORE® EXCLUDER® AAA Endoprosthesis: Is suprarenal fixation useful?
Piergiorgio Cao, Rome, Italy
Piergiorgio Cao, Rome, Italy
Infrarenal vs. suprarenal fixation for short necks: One-year results from UPMC
Robert Rhee, Pittsburgh, PA, United States
Robert Rhee, Pittsburgh, PA, United States
MEDTRONIC SATELLITE
Evidence to build confidence
Chariman: Matt Thompson, London, United Kingdom
The Valiant stent graft for treatment of complicated Type B aortic dissections: 1 year results from VIRTUE trial
Matt Thompson, London, United Kingdom
Matt Thompson, London, United Kingdom
Advances in thoracic endograft deployment: 30 day results of Valiant Captivia registry
Robin Heijmen, Nieuwegein, Netherlands
Robin Heijmen, Nieuwegein, Netherlands
Update on the ENGAGE Endurant global registry: 1 year results
Paul Hayes, Cambridge, United Kingdom
Paul Hayes, Cambridge, United Kingdom
Clinical evidence on proximal protection: Ready to level the playing field
Sumaira Macdonald, Newcastle, United Kingdom
Sumaira Macdonald, Newcastle, United Kingdom
Drug eluting balloons in below the knee: Between clinical studies and clinical practice
Dierk Scheinert, Leipzig, Germany
Dierk Scheinert, Leipzig, Germany
COOK SATELLITE
10.35-11.02
Innovation: Supporting the interventionalist with new disease-specific endovascular devices
Innovation: Supporting the interventionalist with new disease-specific endovascular devices
Moderator: Roy Greenberg, Cleveland, OH, United States
The Zenith Dissection System: A Pathology Specific Solution For Complicated Type B Aortic Dissection
Joseph Lombardi, Camden, NJ, United States
Joseph Lombardi, Camden, NJ, United States
Off-the-shelf fenestrated
Timothy Resch, Malmö, Sweden
Timothy Resch, Malmö, Sweden
VASCUTEK SATELLITE
Chairman: Mauro Gargiulo, Bologna, Italy
Anaconda™: The Italian registry
Giovanni Pratesi, Rome, Italy
Giovanni Pratesi, Rome, Italy
Anaconda™: Planning a fenestrated graft and procedure
Nick Burfitt, Imperial College, London, United Kingdom
Nick Burfitt, Imperial College, London, United Kingdom
Endovascular treatment of ruptured aneurysms - is there a long-term benefit at follow-up?
Robert Geelkerken, Enschede, Netherland
Robert Geelkerken, Enschede, Netherland

